Use of Continuous Glucose Monitoring With Ambulatory Glucose Profile Analysis to Demonstrate the Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 Diabetes.
Phase of Trial: Phase II/III
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Colesevelam (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Jun 2012 Results presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.
- 21 Nov 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 21 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.